Blueprint Genetics is a Helsinki-based, global provider of clinical genetic testing and diagnostics services. The company operates a specialized diagnostic services model, offering a broad menu of over 200 curated test panels, whole exome sequencing, and variant-specific testing to healthcare providers worldwide. It differentiates itself through a strong focus on clinical interpretation, quality accreditation, and support services like variant reevaluation. As a private company, it competes in the rapidly growing market for precision medicine diagnostics.
CardiologyDermatologyEndocrinologyGastroenterologyHematologyHereditary CancerImmunologyMetabolic DisordersMitochondrial DisordersNephrologyNeurologyOphthalmologyPediatricsPulmonologyEar, Nose & ThroatMalformations
Technology Platform
Proprietary clinical-grade next-generation sequencing (NGS) platform with specialized wet-lab protocols, bioinformatics pipelines for difficult-to-sequence regions and mitochondrial DNA analysis, integrated with the Nucleus online portal for clinician interaction.
Funding History
3
Total raised:$240M
Acquisition$195MQuest Diagnostics
Series B$30MBioGeneration Ventures
Series A$15MBioGeneration Ventures
Opportunities
The global shift towards precision medicine and increased clinical adoption of NGS creates a large, growing market for high-quality diagnostic services.
Expansion into new geographies and clinical specialties, along with the development of proactive screening tests, offers significant growth potential.
Risk Factors
Faces intense competition from large diagnostic firms and other genomics companies.
Regulatory changes and reimbursement challenges in key markets pose financial risks.
Rapid technological evolution requires continuous capital investment to maintain platform competitiveness.
Competitive Landscape
Operates in the highly competitive clinical genetic testing market, competing against large commercial labs (e.g., Quest Diagnostics, Laboratory Corporation of America), large pure-play genetic testing companies (e.g., Invitae), and other specialized diagnostic firms. Differentiation is based on clinical focus, test quality, interpretation expertise, and customer support in specific medical specialties.
